DATATRAK’s Technology Driven Drug Development (TD3) Supports Clinical Trial Industry Transformation

Patient-Focused Models, Improving Adherence, and Controlling Costs All Benefit from TD3

CLEVELAND, January 14, 2016 /Marketwired/ – DATATRAK International, Inc. (OTCQX: DTRK), the leader in developing cloud-based, unified dClinical™ technologies and delivering related services for the clinical trials industry, today announced that more than 100 CROs, 10 of the top 15 pharmaceutical organizations, and 3 top 10 biotechs, are using the DATATRAK ONE UX™platform in their efforts to harness technology to drive drug development.

“Technology Driven Drug Development, TD3, is the concept that underlies all technology in DATATRAK‘s product solution portfolio. All of our customers look for every technological edge they can build into their processes.  Maximizing the contribution of human and technological resources and consistently improving cost effectiveness is their daily routine.  We’re delighted that so many organizations are using the power of our DATATRAK ONE UX™ Platform to enable their success,” said Laurence P. Birch, DATATRAK CEO.  He continued, “We’re looking forward to helping the industry drive even greater efficiencies from patient-focused models, capturing big data, and using the resulting insight  to increase the speed and efficacy of drug development.”

Tim Lyons, DATATRAK’s Vice President of Product Development and Operations, stated that, “Our strategic investments in technology are moving the bar to help clinical operations capitalize on the viability of their drug pipelines.  The DATATRAK ONE UX™ platform’s capability to improve and easily configure workflows can make a huge difference as companies work to mitigate risk via adaptive trial design and risk based monitoring.”

Contact DATATRAK today to schedule a demo and see for yourself how you can benefit from TD3.

DATATRAK International, the leader in developing cloud-based, unified dClinicalplatform, is a worldwide technology and services company serving the clinical trials industry. The company delivers a portfolio of software solutions that safely accelerate clinical research, from Concept to Cure®.

 

Join DATATRAK Thought Leaders:

Tweet:  #Technology driving productivity in #clinicalresearch http://ow.ly/X3KUL

About DATATRAK
DATATRAK International is a worldwide technology and services company delivering Unified dClinical solutions and related services for the clinical trials industry. DATATRAK built its multi-component, comprehensive solution on a single, unified platform and expanded this concept to include services delivery via DATATRAK’s Clinical and Consulting Services group. The Company delivers a complete portfolio of software products designed to accelerate the reporting of clinical research data from sites to sponsors and ultimately regulatory authorities, faster and more efficiently than loosely integrated technologies. The DATATRAK ONE® software solution, deployed worldwide through an ASP or Enterprise Transfer offering, supports Phase I – Phase IV drug and device studies in multiple languages throughout the world. DATATRAK has offices located in Chicago, IL; Cary Research Triangle Park (RTP), North Carolina; Bryan, Texas; and Cleveland, Ohio. For more information, visit http://www.datatrak.com.

Except for the historical information contained in this press release, the statements made in this release are forward-looking statements. These forward-looking statements are made based on management’s expectations, assumptions, estimates and current beliefs concerning the operations, future results and prospects of the Company and are subject to uncertainties and factors which are difficult to predict and, in many instances, are beyond the control of the Company, and which could cause actual results to differ materially from those contemplated in these forward-looking statements. For a list of certain factors that may cause actual results to differ materially from those contemplated in these forward looking statements, please see the Company’s report filed with the OTCQX Market on March 13, 2015 announcing its results for the full year period ended December 31, 2014. The Company undertakes no obligation to update publicly or revise any forward-looking statement whether as a result of new information, future events or otherwise.

CONTACT:
Dorothy Radke, Director Marketing, DATATRAK International, Inc., +1-440-443-0082